Current best practice in the evaluation and management of malignant pleural effusions

by Steven Walker, Anna C. Bibby, Nick A. Maskell
Published 2017-02-01

Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial.

by Samuel Alan Stewart, Amelia O Clive, Nick A Maskell, Erika Penz
Published 2018-01-01

A chylothorax in a young woman: The difficulties of medical management

by Eleanor C. Barton, Simon Johnson, Neil Collin, Nidhi Bhatt, Nick A. Maskell
Published 2024-02-01

The management of benign non-infective pleural effusions

by Oliver J. Bintcliffe, Gary Y.C. Lee, Najib M. Rahman, Nick A. Maskell
Published 2016-09-01

Commentary: considerations for using the ‘Trials within Cohorts’ design in a clinical trial of an investigational medicinal product

by Anna C. Bibby, David J. Torgerson, Samantha Leach, Helen Lewis-White, Nick A. Maskell
Published 2018-01-01

Frailty Prevalence and Association with Clinical Outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease

by Alessia Verduri, Ben Carter, Ceara Rice, James Laraman, Eleanor Barton, Enrico Clini, Nick A. Maskell, Jonathan Hewitt
Published 2023-08-01

Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT

by Rahul Bhatnagar, Ramon Luengo-Fernandez, Brennan C Kahan, Najib M Rahman, Robert F Miller, Nick A Maskell
Published 2020-06-01

Pneumothorax management: current state of practice in the UK

by Rob J. Hallifax, Mark Roberts, Nicky Russell, Magda Laskawiec-Szkonter, Steve P. Walker, Nick A. Maskell, Najib M. Rahman
Published 2022-02-01

A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma

by Duneesha de Fonseka, David T. Arnold, Louise Stadon, Anna Morley, Emma Keenan, Michael Darby, Lynne Armstrong, Paul Virgo, Nick A. Maskell
Published 2018-02-01

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

by Anna C. Bibby, Selina Tsim, Nikolaos Kanellakis, Hannah Ball, Denis C. Talbot, Kevin G. Blyth, Nick A. Maskell, Ioannis Psallidas
Published 2016-12-01

Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings.

by Fiona J McCann, Stephen J Chapman, Wai Cho Yu, Nick A Maskell, Robert J O Davies, Y C Gary Lee
Published 2012-01-01

A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial

by David T. Arnold, Emma Tucker, Anna Morley, Alice Milne, Louise Stadon, Sonia Patole, George W. Nava, Steven P. Walker, Nick A. Maskell
Published 2022-08-01

Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre...

by Anna C. Bibby, Duneesha De Fonseka, Anna J. Morley, Emma Keenan, Alfredo Addeo, Sarah Smith, Anthony J. Edey, Nick A. Maskell
Published 2017-12-01

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma

by Duneesha De Fonseka, David T. Arnold, Anna J. Morley, Mary Brett, Nidhi Bhatt, Anthony Edey, Richard Daly, Anna C. Bibby, Nick A. Maskell
Published 2022-04-01

Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance

by Selina Tsim, Kevin G Blyth, Najib M Rahman, Nick A Maskell, Matthew Evison, Rachel Mercer, Katie Ferguson, Jenny King, Matthew Neilson, Kelly Marshall, Hugh Welch
Published 2023-08-01

Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)

by Kevin G Blyth, Nick A Maskell, Louise Stadon, John E Harvey, Anna C Bibby, Charles Comins, Ruairi J H Conway, Jenny Symonds, Deborah Walton, Janet Probets
Published 2022-11-01

A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology

by Anna C. Bibby, Natalie Zahan-Evans, Emma Keenan, Charles Comins, John E. Harvey, Helen Day, Najib M. Rahman, Janet E. Fallon, Rachael Gooberman-Hill, Nick A. Maskell
Published 2022-09-01

Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort

by Ruairi J.H. Conway, Natalie Smith, William Cooper, Geraldine Lynch, Sonia Patole, Jenny Symonds, Anthony Edey, Nick A. Maskell, Anna C. Bibby, on behalf of the ASSESS-meso Collaborative group, Natalie Zahan-Evans
Published 2023-12-01

Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial

by Duneesha de Fonseka, Anna Morley, Louise Stadon, Emma Keenan, Steven Walker, Sarah Smith, John E. Harvey, R. Ashley Cox, Adam Dangoor, Charles Comins, Christine Rogers, Anthony Edey, Alfredo Addeo, Nick A. Maskell
Published 2018-08-01

A clinical observational analysis of aerosol emissions from dental procedures.

by Tom Dudding, Sadiyah Sheikh, Florence Gregson, Jennifer Haworth, Simon Haworth, Barry G Main, Andrew J Shrimpton, Fergus W Hamilton, AERATOR group, Anthony J Ireland, Nick A Maskell, Jonathan P Reid, Bryan R Bzdek, Mark Gormley
Published 2022-01-01